BRIEF published on 12/11/2024 at 12:13, 1 year 6 months ago Threshold crossing by Bpifrance in ABIONYX PHARMA Voting Rights Actions Threshold Crossing Bpifrance ABIONYX
PRESS RELEASE published on 12/11/2024 at 12:11, 1 year 6 months ago Franchissement de seuil Déclaration de franchissement de seuil de 5% des droits de vote de ABIONYX PHARMA par la Caisse des dépôts et consignations via Bpifrance Participations Franchissement De Seuil Caisse Des Dépôts Et Consignations ABIONYX Pharma Bpifrance Participations 5% Droits De Vote
PRESS RELEASE published on 12/11/2024 at 12:08, 1 year 6 months ago Franchissement de seuil Bpifrance declared indirectly holding 4.67% of Abionyx Pharma's capital and 7.34% of voting rights as of December 5, 2024 Déclaration Franchissement De Seuil AMF Bpifrance ABIONYX Pharma
BRIEF published on 12/10/2024 at 10:51, 1 year 6 months ago Franchissement de seuil par Cyrille Tupin chez ABIONYX PHARMA Droits De Vote Franchissement De Seuil Actions ABIONYX Pharma Cyrille Tupin
BRIEF published on 12/10/2024 at 10:51, 1 year 6 months ago Threshold crossing by Cyrille Tupin at ABIONYX PHARMA Voting Rights Actions Threshold Crossing ABIONYX Pharma Cyrille Tupin
PRESS RELEASE published on 12/10/2024 at 10:46, 1 year 6 months ago Franchissement de seuil Déclaration de franchissement de seuil par M. Cyrille Tupin concernant ABIONYX PHARMA. Détention de 4,56% du capital et 6,06% des droits de vote Déclaration Droits De Vote Franchissement De Seuil ABIONYX Pharma Cyrille Tupin
BRIEF published on 11/14/2024 at 19:05, 1 year 7 months ago ABIONYX Pharma : Bilan financier du troisième trimestre 2024 Chiffre D'affaires Biotechnologie Trésorerie ABIONYX Pharma T3 2024
BRIEF published on 11/14/2024 at 19:05, 1 year 7 months ago ABIONYX Pharma: Third quarter 2024 financial report Biotechnology Treasury Turnover Q3 2024 ABIONYX Pharma
PRESS RELEASE published on 11/14/2024 at 19:00, 1 year 7 months ago Information financière trimestrielle / Information financière du troisième trimestre ABIONYX Pharma communique son chiffre d'affaires et sa trésorerie du 3ème trimestre 2024. Retransmission de l'AGE le 28 novembre 2024 Chiffre D'affaires Trésorerie ABIONYX Pharma 3ème Trimestre 2024 Retransmission AGE
PRESS RELEASE published on 11/14/2024 at 19:00, 1 year 7 months ago Quarterly financial reporting / Third quarter financial report ABIONYX Pharma reports Q3 2024 revenue of €3.4m and cash position of €4.1m before IRIS Pharma's CIR receipt. General Meeting on November 28, 2024, at 2.00 pm CET Cash Position General Meeting Biotech Company ABIONYX Pharma Revenue Update
Published on 06/24/2026 at 21:20, 24 minutes ago Taranis to Explore New Properties East of Thor Mineral Resource
Published on 06/24/2026 at 20:10, 1 hour 34 minutes ago Fox River Obtains Final Order Approving Plan of Arrangement With Avenir Minerals Limited
Published on 06/24/2026 at 14:45, 6 hours 59 minutes ago Amdocs Selected by Three Scandinavia to Support Customer Engagement Transformation Across Nordic Markets
Published on 06/24/2026 at 14:00, 7 hours 44 minutes ago GameSquare and U.S. Army Partner for Soldier Showdown 8, Presented by USAA
Published on 06/24/2026 at 20:54, 49 minutes ago EQS-Adhoc: Branicks Group AG sets out timetable for the publication of its 2025 annual and consolidated financial statements
Published on 06/24/2026 at 18:25, 3 hours 18 minutes ago Huawei Helps Global Carriers Monetize Tokens with Service-Network-Compute Integration
Published on 06/24/2026 at 18:25, 3 hours 18 minutes ago Annual General Meeting of Highlight Event and Entertainment AG
Published on 06/24/2026 at 19:00, 2 hours 44 minutes ago ALTAREA - Succès de l’option pour le paiement du dividende en actions : taux de souscription de 78,5 %
Published on 06/24/2026 at 18:00, 3 hours 44 minutes ago KERLINK : Assemblée générale mixte des actionnaires du 23 juin 2026 Seconde convocation le 9 juillet 2026.
Published on 06/24/2026 at 17:45, 3 hours 59 minutes ago Air Liquide poursuit son développement au Kazakhstan avec un investissement clé pour le complexe industriel de Silleno
